Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa
Abstract
In South Africans, the RV144 HIV vaccine regimen elicited robust immune responses that have been associated with vaccine efficacy.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 18, 2019
- Source ID
- 10.1126/scitranslmed.aax1880
Entities
People
- Abby Isaacs
- April K Randhawa
- Britta Flach
- Carlos A. Diazgranados
- Carter Lee
- Craig Innes
- David C. Montefiori
- Edith M Swann
- Erica Andersen-nissen
- Erica Lazarus
- Faruk Sinangil
- Fatima Laher
- Georgia D. Tomaras
- Glenda Gray
- Guido Ferrari
- James Kublin
- John Hural
- Julie McElrath
- Lawrence Corey
- Linda-Gail Bekker
- Lynn Morris
- Merlin L Robb
- Nelson Michael
- Nicole Grunenberg
- Nicole Yates
- Nonhlanhla N Mkhize
- Peter B Gilbert
- Ryan Jensen
- Sanjay Phogat
- Sheetal Sawant
- Stephen C. De Rosa
- Surita Roux
- Xiaoying Shen
- Ying Huang
Organizations
- Aurum Institute
- Duke University
- Fred Hutchinson Cancer Center
- Gates Foundation
- Global Solutions for Infectious Diseases
- James B. Pendleton Charitable Trust
- National Institute for Communicable Diseases
- National Institute of Allergy and Infectious Diseases
- Sanofi Pasteur
- South African Medical Research Council
- United States Military HIV Research Program
- University of Cape Town
- University of the Witwatersrand